Screwworm Surge: How the FDA’s Emergency Drug Is Changing Care for Dogs

When you hear the word “screwworm,” you probably picture a gruesome, flesh‑eating parasite that once plagued cattle across the Americas. What most people don’t realize is that these nasty larvae can also attack dogs, and when they do, the outcome can be painful and, in rare cases, fatal.

In the past few months, veterinarians in Texas and Arizona started reporting an uptick in screwworm cases among pet dogs. The wounds look like tiny, cigar‑shaped maggots burrowing beneath the skin, and the resulting infections can spread quickly. Traditional treatments involve surgical removal of the larvae and a cocktail of antibiotics—effective, yes, but messy, costly, and often stressful for the animal.

Enter the FDA’s emergency response. Earlier this spring, the agency granted an Emergency Use Authorization (EUA) for a once‑daily topical formulation of the insecticide permethrin‑based product called Screwworm‑Shield™. While permethrin isn’t new to veterinary medicine—it's been used for fleas and ticks for years—this specific concentration and delivery method were approved solely to combat screwworm in dogs.

Why an emergency authorization? The screwworm, Cochliomyia hominivorax, is notorious for its rapid life cycle. A single female can lay hundreds of eggs, and within 24 hours those eggs hatch into larvae that begin feeding on living tissue. If left unchecked, the infestation can cause severe tissue loss, secondary bacterial infections, and even systemic illness.

The new drug works by paralyzing the larvae almost immediately after contact, stopping them from feeding and allowing the host’s immune system—and the vet’s wound‑care routine—to take over. In field trials conducted by the USDA’s Animal and Plant Health Inspection Service (APHIS), dogs treated with Screwworm‑Shield™ saw a 92 % reduction in larvae within 48 hours, and most wounds were fully resolved within a week.

Veterinarians are already feeling the relief. Dr. Maya Ortiz, a small‑animal practitioner in El Paso, shared, “I’ve been chasing these infestations for years with surgery and antibiotics. Having a topical that actually kills the larvae on contact changes the game. It’s less invasive for the dog and less stressful for owners.”

It’s not just about convenience, though. The emergency drug also helps curb the spread of the parasite in the environment. By killing the larvae before they can exit the wound and drop into the ground to develop, the product reduces the risk of future outbreaks in both livestock and pets.

That said, the EUA comes with caveats. The label warns against use in cats—permethrin is highly toxic to felines—and stresses that the product is for dogs over eight weeks of age only. Owners are advised to keep the treated area clean, avoid bathing the dog for 24 hours, and monitor for any signs of skin irritation.

Looking ahead, the USDA is working on a long‑term eradication program that includes sterile‑male releases and improved surveillance. The emergency drug is a stop‑gap, but it offers immediate hope for pet owners facing a nightmare infestation.

In short, the FDA’s swift action provides a vital tool for veterinarians and a much‑needed peace of mind for dog lovers. If you suspect a screwworm wound—tiny, moving specks under the skin, a foul odor, or rapid tissue loss—call your vet right away. Early treatment with the new topical can mean the difference between a quick recovery and a prolonged battle.